PARP inhibition in platinum-based chemotherapy: Chemopotentiation and neuroprotection

Full text for this resource is not available from the Research Repository.

McQuade, Rachel, Stojanovska, Vanesa, Bornstein, Joel C ORCID: 0000-0002-7518-7717 and Nurgali, Kulmira ORCID: 0000-0002-2597-6929 (2018) PARP inhibition in platinum-based chemotherapy: Chemopotentiation and neuroprotection. Pharmacological Research, 137. pp. 104-113. ISSN 1043-6618

Dimensions Badge

Altmetric Badge

Item type Article
URI https://vuir.vu.edu.au/id/eprint/38441
DOI 10.1016/j.phrs.2018.09.031
Official URL https://www.sciencedirect.com/science/article/pii/...
Subjects Historical > FOR Classification > 1112 Oncology and Carcinogenesis
Current > Division/Research > Institute for Health and Sport
Current > Division/Research > College of Health and Biomedicine
Keywords platinum-based chemotherapeutic agent ; anti-cancer therapy ; chemopotentiating effects ; polymerase inhibitors ; peripheral neuropathy
Citations in Scopus 29 - View on Scopus
Download/View statistics View download statistics for this item

Search Google Scholar

Repository staff login